UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

Annals of oncology, 2016-02, Vol.27 (2), p.300-305

2016

Volltextzugriff (PDF)

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

British journal of cancer, 2014-11, Vol.111 (11), p.2051-2057

2014

Volltextzugriff (PDF)

Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy

Experimental oncology, 2015-12, Vol.37 (4), p.298

2015

Volltextzugriff (PDF)

Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma

Neoplasma, 2013-01, Vol.60 (1), p.83-91

2013

Volltextzugriff (PDF)

Bone mineral density in early breast cancer patients

Bratislavské lékarské listy, 2010, Vol.111 (1), p.27-32

2010

Volltextzugriff (PDF)

Non-correlation between CRP and rapid diagnostic tests for malaria among rural population in Southern Uganda (Original research paper)

Clinical social work journal / CWS, 2017-01, Vol.8 (3), p.31-33

2017

Volltextzugriff (PDF)

Bonemineral density (BMD) in patientswith germcell tumors (GCT)

Bone (New York, N.Y.), 2009-05, Vol.44, p.S167-S167

2009

Volltextzugriff (PDF)

Low Prevalence of MRSA in Physiotherapy and Gym Facilities in a Greek Refugee Camp

Clinical social work journal / CWS, 2017-01, Vol.8 (2), p.35-37

2017

Volltextzugriff (PDF)

Religion and infectious diseases – review

Clinical social work journal / CWS, 2017-01, Vol.8 (2), p.29-34

2017

Volltextzugriff (PDF)

Spectrum of Bacterial Isolates and Diagnoses in Physiotherapy and Rehabilitation Facility before and after Armed Conflict in Iraq (Research Note)

Clinical social work journal / CWS, 2017-01, Vol.8 (3), p.15-17

2017

Volltextzugriff (PDF)

Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients

Neoplasma, 2009, Vol.56 (3), p.275-278

2009

Volltextzugriff (PDF)

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy : analysis of aetiology risk factors and outcome

Journal of antimicrobial chemotherapy, 1998-03, Vol.41 (3), p.373-380

1998

Volltextzugriff (PDF)

Hematogenous trichosporonosis in cancer patients : report of 12 cases including 5 during prophylaxis with itraconazol

Supportive care in cancer, 1999, Vol.7 (1), p.39-43

1999

Volltextzugriff (PDF)

Circulating tumour cells in breast cancer--review

Klinická onkologie, 2010, Vol.23 (2), p.86-91

2010

Volltextzugriff (PDF)

Bone mineral density in patients with thyroid cancer on suppressive therapy after total thyroidectomy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e19739-e19739

2011

Volltextzugriff (PDF)

An unusual presentation of testicular cancer

Bratislavské lékarské listy, 2008, Vol.109 (12), p.576-579

2008

Volltextzugriff (PDF)

Survival is associated with circulating cytokine levels in metastatic testicular germ cell tumors

Annals of oncology, 2016-10, Vol.27, p.vi539-vi539

2016

Volltextzugriff (PDF)

Predictors of inferior outcome in community acquired bacterial meningitis

Neuro-endocrinology letters, 2007-11, Vol.28 Suppl 3, p.2

2007

Volltextzugriff (PDF)

Nosocomial meningitis caused by Staphylococcus other than S. aureus in children: multicentre study

Neuro-endocrinology letters, 2007-06, Vol.28 Suppl 2, p.34-35

2007

Volltextzugriff (PDF)

Nosocomial catheter-associated Flavobacterium odoratum bacteraemia in cancer patients

Journal of medical microbiology, 1998-02, Vol.47 (2), p.183-183

1998

Volltextzugriff (PDF)

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

The lancet oncology, 2013-02, Vol.14 (2), p.125-133

2013

Volltextzugriff (PDF)

2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients

European journal of cancer supplements, 2007, Vol.5 (4), p.211-212

2007

Volltextzugriff (PDF)

Fungaemia due to Fusarium spp. in cancer patients

The Journal of hospital infection, 1997-07, Vol.36 (3), p.223-228

1997

Volltextzugriff (PDF)

Abstract P6-06-40: Analysis of outcome according to risk factors in the randomized phase III TURANDOT trial evaluating first-line bevacizumab-containing therapy for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-06-40

2013

Volltextzugriff (PDF)

PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.131-131

2004

Volltextzugriff (PDF)

1 – 25 von 428

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(335)
Mit Volltextzugriff
(320)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(261)
Life Sciences & Biomedicine
(175)
Humans
(95)
Physical Sciences
(85)
Chemistry
(80)
Male
(49)
Female
(48)
Biological And Medical Sciences
(47)
Oncology
(47)
Chemistry, Analytical
(46)
Technology
(46)
Adult
(44)
Engineering
(41)
Middle Aged
(41)
Medical Sciences
(40)
Engineering, Electrical & Electronic
(35)
Neoplasms - Complications
(35)
Infectious Diseases
(34)
Risk Factors
(34)
Gas Chromatography
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy

Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma

Bone mineral density in early breast cancer patients

Non-correlation between CRP and rapid diagnostic tests for malaria among rural population in Southern Uganda (Original research paper)

Bonemineral density (BMD) in patientswith germcell tumors (GCT)

Low Prevalence of MRSA in Physiotherapy and Gym Facilities in a Greek Refugee Camp

Religion and infectious diseases – review

Spectrum of Bacterial Isolates and Diagnoses in Physiotherapy and Rehabilitation Facility before and after Armed Conflict in Iraq (Research Note)

Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy : analysis of aetiology risk factors and outcome

Hematogenous trichosporonosis in cancer patients : report of 12 cases including 5 during prophylaxis with itraconazol

Circulating tumour cells in breast cancer--review

Bone mineral density in patients with thyroid cancer on suppressive therapy after total thyroidectomy

An unusual presentation of testicular cancer

Survival is associated with circulating cytokine levels in metastatic testicular germ cell tumors

Predictors of inferior outcome in community acquired bacterial meningitis

Nosocomial meningitis caused by Staphylococcus other than S. aureus in children: multicentre study

Nosocomial catheter-associated Flavobacterium odoratum bacteraemia in cancer patients

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients

Fungaemia due to Fusarium spp. in cancer patients

Abstract P6-06-40: Analysis of outcome according to risk factors in the randomized phase III TURANDOT trial evaluating first-line bevacizumab-containing therapy for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER

Suchergebnisse filtern